BioCentury
ARTICLE | Clinical News

Transdermal ibuprofen-VALE cream: Phase II data

January 2, 2012 8:00 AM UTC

A double-blind, Swiss Phase II trial in 75 patients with moderate to severe OA of the knee showed that twice-daily BC-IBU-CH-001 significantly reduced pain as measured by WOMAC pain scores from baseli...